What is Polycystic Ovarian Syndrome?
Polycystic Ovary Syndrome (PCOS) is a heterogeneous disorder characterized by hyperandrogenism and chronic anovulation. PCOS is characterized by excessive ovarian and/or adrenal androgen secretion. PCOS have a hormonal imbalance and metabolism problems that may affect their overall health and appearance. PCOS is also a common and treatable cause of infertility.
How many people are affected by Polycystic Ovarian Syndrome?
- Polycystic ovary syndrome (PCOS) is a health problem that affects 1 in 10 women of childbearing age.
- PCOS is one of the most common causes of female infertility, affecting 6% to 12% of women of reproductive age in the United States.
- There is no test to definitively diagnose PCOS. Even though PCOS is fairly common, it is often misdiagnosed.
Request for free sample pages @ Polycystic Ovarian Syndrome Market Trends
How will Polycystic Ovarian Syndrome Market change in upcoming years?
Increase in the Polycystic Ovary Syndrome prevalence, along with the expected launch of emerging therapies will boost the Polycystic Ovary Syndrome market in the forecasted period [2020-2030].
Companies across the globe are diligently working toward the development of novel treatment therapies with a considerable amount of success over the years.
Key players, such as Zydus Discovery DMCC, Spruce Biosciences, Kindex Pharmaceuticals etc., are developing drugs for the Polycystic Ovary Syndrome treatment market.
Request for free sample pages @ Polycystic Ovarian Syndrome Market Size